- Home
- EDBL vs XBIO Comparison
EDBL vs XBIO Comparison
Compare EDBL & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- XBIO
- Stock Information
- Founded
- EDBL 2020
- XBIO N/A
- Country
- EDBL United States
- XBIO United States
- Employees
- EDBL N/A
- XBIO N/A
- Industry
- EDBL Farming/Seeds/Milling
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- XBIO Health Care
- Exchange
- EDBL Nasdaq
- XBIO Nasdaq
- Market Cap
- EDBL 6.1M
- XBIO 6.3M
- IPO Year
- EDBL 2022
- XBIO N/A
- Fundamental
- Price
- EDBL $0.28
- XBIO $4.24
- Analyst Decision
- EDBL
- XBIO Hold
- Analyst Count
- EDBL 0
- XBIO 1
- Target Price
- EDBL N/A
- XBIO N/A
- AVG Volume (30 Days)
- EDBL 44.7M
- XBIO 11.0K
- Earning Date
- EDBL 11-13-2024
- XBIO 11-12-2024
- Dividend Yield
- EDBL N/A
- XBIO N/A
- EPS Growth
- EDBL N/A
- XBIO N/A
- EPS
- EDBL N/A
- XBIO N/A
- Revenue
- EDBL $14,069,000.00
- XBIO $2,523,427.00
- Revenue This Year
- EDBL $2.43
- XBIO N/A
- Revenue Next Year
- EDBL $42.42
- XBIO N/A
- P/E Ratio
- EDBL N/A
- XBIO N/A
- Revenue Growth
- EDBL 7.88
- XBIO 7.15
- 52 Week Low
- EDBL $0.12
- XBIO $2.78
- 52 Week High
- EDBL $12.47
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- EDBL 54.09
- XBIO 53.05
- Support Level
- EDBL $0.21
- XBIO $3.93
- Resistance Level
- EDBL $0.42
- XBIO $4.32
- Average True Range (ATR)
- EDBL 0.05
- XBIO 0.25
- MACD
- EDBL -0.01
- XBIO 0.01
- Stochastic Oscillator
- EDBL 32.71
- XBIO 84.31
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.